273 related articles for article (PubMed ID: 33485971)
1. Dissecting the novel mechanism of reduning injection in treating Coronavirus Disease 2019 (COVID-19) based on network pharmacology and experimental verification.
Jia S; Luo H; Liu X; Fan X; Huang Z; Lu S; Shen L; Guo S; Liu Y; Wang Z; Cao L; Cao Z; Zhang X; Zhou W; Zhang J; Li J; Wu J; Xiao W
J Ethnopharmacol; 2021 Jun; 273():113871. PubMed ID: 33485971
[TBL] [Abstract][Full Text] [Related]
2. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
3. Pathway network-based quantitative modeling of the time-dependent and dose-response anti-inflammatory effect of Reduning Injection.
Xie F; Xie M; Yang Y; Ao W; Zhao T; Liu N; Chen B; Kang W; Xiao W; Gu J
J Ethnopharmacol; 2023 May; 307():116216. PubMed ID: 36736714
[TBL] [Abstract][Full Text] [Related]
4. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
Xing Y; Hua YR; Shang J; Ge WH; Liao J
Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Anti-inflammatory Mechanism of Reduning Injection by Network Pharmacology.
Xie F; Xie M; Yang Y; Zhang M; Xu X; Liu N; Xiao W; Gu J
Biomed Res Int; 2020; 2020():6134098. PubMed ID: 33381562
[TBL] [Abstract][Full Text] [Related]
7. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L
Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688
[TBL] [Abstract][Full Text] [Related]
8. In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019.
Wu H; Gong K; Qin Y; Yuan Z; Xia S; Zhang S; Yang J; Yang P; Li L; Xie M
J Ethnopharmacol; 2021 Jul; 275():114098. PubMed ID: 33831468
[TBL] [Abstract][Full Text] [Related]
9. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Components of
Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
[TBL] [Abstract][Full Text] [Related]
12. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease.
Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S
IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400
[TBL] [Abstract][Full Text] [Related]
13. Reduning injection and its effective constituent luteoloside protect against sepsis partly via inhibition of HMGB1/TLR4/NF-κB/MAPKs signaling pathways.
Wang Z; Chen W; Li Y; Zhang S; Lou H; Lu X; Fan X
J Ethnopharmacol; 2021 Apr; 270():113783. PubMed ID: 33421596
[TBL] [Abstract][Full Text] [Related]
14. Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.
Ye XW; Deng YL; Zhang X; Liu MM; Liu Y; Xie YT; Wan Q; Huang M; Zhang T; Xi JH; Zhang JL
Drug Dev Ind Pharm; 2021 Aug; 47(8):1279-1289. PubMed ID: 34605344
[TBL] [Abstract][Full Text] [Related]
15. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS
Zhang ZJ; Wu WY; Hou JJ; Zhang LL; Li FF; Gao L; Wu XD; Shi JY; Zhang R; Long HL; Lei M; Wu WY; Guo DA; Chen KX; Hofmann LA; Ci ZH
J Integr Med; 2020 May; 18(3):229-241. PubMed ID: 32307268
[TBL] [Abstract][Full Text] [Related]
16. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.
Zhao J; Tian S; Lu D; Yang J; Zeng H; Zhang F; Tu D; Ge G; Zheng Y; Shi T; Xu X; Zhao S; Yang Y; Zhang W
Phytomedicine; 2021 May; 85():153315. PubMed ID: 32978039
[TBL] [Abstract][Full Text] [Related]
17. Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019.
Li J; Guo S; Tan Y; Zhang J; Wu Z; Stalin A; Zhang F; Huang Z; Wu C; Liu X; Huang J; Wu J
Medicine (Baltimore); 2023 Aug; 102(34):e34866. PubMed ID: 37653800
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
[TBL] [Abstract][Full Text] [Related]
19. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
[TBL] [Abstract][Full Text] [Related]
20. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study.
Xia L; Shi Y; Su J; Friedemann T; Tao Z; Lu Y; Ling Y; Lv Y; Zhao R; Geng Z; Cui X; Lu H; Schröder S
Phytomedicine; 2021 May; 85():153390. PubMed ID: 33158717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
